FDA approves first rescue treatment of asthma for adults Dr. Kamal Kant Kohli13 Jan 2023 8:00 PM ISTThe US Food and Drug Administration (FDA) has approved albuterol/budesonide (Airsupra) for prevention and treatment of bronchoconstriction and to...
Dr Reddy's Labs, Theranica collaborate for commercialisation of wearable migraine treatment Nerivio in India Ruchika Sharma12 Jan 2023 12:36 PM ISTNerivio is the FDA-cleared, prescribed, digitally connected, drug-free wearable device for the acute treatment of episodic and chronic migraine in...
Rocatinlimab shows promising long-term results for Moderate to Severe Atopic Dermatitis: Lancet Dr. Kamal Kant Kohli12 Dec 2022 10:45 AM ISTRocatinlimab is a novel, patient-tailored monoclonal antibody therapy. Role of rocatinlimab as a safe and effective treatment for atopic...
Esketamine nasal spray found superior to quetiapine extended-release in resistant depression in phase 3 trial Dr. Kamal Kant Kohli30 Nov 2022 8:00 PM ISTEsketamine nasal spray was found superior to to quetiapine extended-release (XR) in adults with treatment-resistant major depressive disorder,...
MRI reveals significant brain abnormalities post-COVID upto six months Dr. Kamal Kant Kohli21 Nov 2022 8:00 PM ISTResearchers have uncovered brain changes in patients up to six months after they recovered from COVID-19, by using a special type of MRI.The study is...
Prevalence of Trigger Factors and Associated Disorders in Tension-type Headache Dr. Nandita Mohan12 Nov 2022 9:30 AM ISTHeadache is most common pain suffered by many. Tension-type headache is the most common primary headache disorder. As per the Global Burden of...
Fezolinetant safe and effective treatment for VMS associated with menopause: Phase 3 SKYLIGHT trial Dr. Kamal Kant Kohli19 Oct 2022 12:15 PM ISTUSA: According to data presented at the NAMS Annual Meeting, women using fezolinetant for moderate to severe vasomotor symptoms experienced a...
Cognitive Behavioral Therapy significantly reduces headache disability, PTSD following brain injury Dr. Kamal Kant Kohli6 July 2022 9:00 AM ISTSAN ANTONIO: Cognitive Behavioral Therapy is the first therapy to be developed specifically for post-traumatic headache that may significantly reduce...
Top Medical Bulletin 29/Jund/2022 Dr. Nandita Mohan29 Jun 2022 5:30 PM ISTHere are the top medical stories for today:New therapy to reduce Headache, PTSD following brain injury Effective treatments exist...
Acupuncture may reduce attacks of chronic Tension-type headaches Dr. Kamal Kant Kohli25 Jun 2022 10:45 AM ISTTension-type headaches most often involve a pressing or tightening feeling on both sides of the head with mild to moderate intensity. These headaches...
Lidocaine infusions help relieve pain in unresponsive chronic migraine Dr. Kamal Kant Kohli19 Jun 2022 7:30 PM ISTInfusions of the local anesthetic lidocaine may provide some pain relief to people with chronic migraine that does not respond to other treatments,...
Strides Pharma Ibuprofen Oral Suspension gets USFDA okay Ruchika Sharma11 Jun 2022 11:45 AM ISTBengaluru: Strides Pharma Science Limited has recently announced that its stepdown wholly owned subsidiary, Strides Pharma Global Pte. Limited,...
